{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:49:12Z","timestamp":1791888552952,"version":"4.3.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[1995,12]]},"abstract":"<jats:p>\n            <jats:italic>Background and Purpose<\/jats:italic>\n            Hypertensive hypervolemic therapy has been shown to reverse delayed ischemic deficits after aneurysmal subarachnoid hemorrhage. Concern has been raised about systemic complications of therapy, including pulmonary edema and myocardial ischemia, especially when high doses of vasopressors are used. Patients in whom delayed ischemic deficits were treated with hypervolemia and phenylephrine were prospectively evaluated for signs of systemic toxicity.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Methods<\/jats:italic>\n            Twenty-four consecutive patients treated with hypertensive hypervolemic therapy after aneurysmal subarachnoid hemorrhage were studied. Sixty-seven percent had underlying cardiac disease, vascular disease, or hypertension. No patient was excluded because of age or preexisting cardiac disease. Patients were closely monitored for signs of congestive heart failure (physical examination, chest x-ray films, arterial blood gases, cardiac index, pulmonary artery wedge pressure, and oxygen requirement). Indicators of cardiac ischemia and other extracerebral toxicity that were monitored included cardiac enzymes, electrocardiograms, serum creatinine, electrolyte and lactic acid levels, gastrointestinal motility, and urine output.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Results<\/jats:italic>\n            Volume expansion and phenylephrine infusion produced an increase in several hemodynamic parameters including pulmonary artery wedge pressure, which rose 28% (13\u00b13.6 to 16\u00b11.9 mm Hg), mean arterial blood pressure, which rose 25% (99\u00b112.5 to 123\u00b111.4 mm Hg), and systemic vascular resistance, which rose 46% (1234\u00b1294 to 1739\u00b1315 dyne \u00b7 s\n            <jats:sup>\u22121<\/jats:sup>\n            \u00b7 cm\n            <jats:sup>\u22125<\/jats:sup>\n            ); however, there was no change in cardiac index (3.9\u00b10.9 to 4.0\u00b10.6 L \u00b7 min\n            <jats:sup>\u22121<\/jats:sup>\n            \u00b7 m\n            <jats:sup>\u22122<\/jats:sup>\n            ). There were no clinically significant episodes of pulmonary edema requiring a change in vasopressor therapy and no myocardial infarctions. Phenylephrine was stopped in only one patient (incidence, 4%; 95% confidence interval, 0% to 12%), who developed an exacerbation of his preexisting bradycardia. There was no evidence of noncardiac organ system toxicity. Eighty-eight percent of the patients exhibited neurological improvement.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Conclusions<\/jats:italic>\n            Hypertensive hypervolemic therapy with the use of high-dose phenylephrine can be administered with acceptable systemic toxicity, even in patients with previous cardiac disease, provided that close monitoring is performed. To minimize risk, aggressive treatment should probably be reserved for patients with signs of delayed ischemia rather than administered prophylactically.\n          <\/jats:p>","DOI":"10.1161\/01.str.26.12.2260","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T20:10:52Z","timestamp":1308341452000},"page":"2260-2266","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":80,"title":["Safety of Hypertensive Hypervolemic Therapy With Phenylephrine in the Treatment of Delayed Ischemic Deficits After Subarachnoid Hemorrhage"],"prefix":"10.1161","volume":"26","author":[{"given":"Janice A.","family":"Miller","sequence":"first","affiliation":[{"name":"From the Departments of Neurology (J.A.M., M.N.D.) and Neurosurgery (R.G.D., M.N.D.), Neurology\/Neurosurgery Intensive Care Unit, Washington University School of Medicine, St Louis, Mo."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Ralph G.","family":"Dacey","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (J.A.M., M.N.D.) and Neurosurgery (R.G.D., M.N.D.), Neurology\/Neurosurgery Intensive Care Unit, Washington University School of Medicine, St Louis, Mo."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Diringer","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (J.A.M., M.N.D.) and Neurosurgery (R.G.D., M.N.D.), Neurology\/Neurosurgery Intensive Care Unit, Washington University School of Medicine, St Louis, Mo."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1990.73.1.0018"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1985.62.4.0539"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1979.50.5.0587"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.42.10.899"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-198606000-00026"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-198209000-00001"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-198812000-00002"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.18.2.3564092"},{"key":"e_1_3_2_9_2","unstructured":"Heerdt PM Forstot RM. Heart rate control. In: Chernow B ed. Essentials of Critical Care Pharmacology 2nd ed. Baltimore Md: Williams & Wilkins Co; 1993:297-312."},{"key":"e_1_3_2_10_2","unstructured":"Starkey K Docherty JR. Alpha-1 and alpha-2 adrenoreceptors: pharmacology and clinical implications. J Cardiovasc Pharmacol. 1981;3(suppl 1):514-516."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199111000-00016"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198207000-00003"},{"key":"e_1_3_2_13_2","first-page":"571","volume":"68","year":"1989","unstructured":"Schwinn DA, Reves JG. Time course and hemodynamic effects of alpha-1 adrenergic bolus administration in anesthetized patients with myocardial disease. Anesth Analg. 1989;68:571-578.","journal-title":"Anesth Analg"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(79)90219-4"},{"key":"e_1_3_2_15_2","unstructured":"Iberti TJ Silverstein JH. Complications of pulmonary artery catheterization. In: Sprung CL ed. The Pulmonary Artery Catheter. 2nd ed. Closter NJ: Critical Care Research Associates Inc; 1993."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-197903000-00005"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-198409000-00010"},{"key":"e_1_3_2_18_2","first-page":"364","volume":"3","year":"1978","unstructured":"Pritz MB, Giannotta SL, Kindt GW, Mc Gillicuddy JE, Prager RL. Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion. Neurosurgery. 1978;3:364-368.","journal-title":"Neurosurgery"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.22.9.978"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1985.62"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199201000-00003"},{"key":"e_1_3_2_22_2","first-page":"248","volume":"25","year":"1994","unstructured":"Coyne TJ, Wallace MC, Sinclair F. Pulmonary edema following prophylactic hypervolemia after subarachnoid hemorrhage. Stroke. 1994;25:248. Abstract.","journal-title":"Stroke"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.5.815"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.37.6.755"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.10.5.505497"},{"key":"e_1_3_2_26_2","first-page":"88","volume":"1","year":"1989","unstructured":"Hart GK, Humphrey L, Weiss J. Subarachnoid hemorrhage: cardiac complications. Crit Care Report. 1989;1:88-92.","journal-title":"Crit Care Report"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(88)80044-5"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/67.1.58"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1993.79.4.0494"},{"key":"e_1_3_2_30_2","first-page":"A345","volume":"44","year":"1994","unstructured":"Lennihan L, Solomon RA, Mayer S, Prohovnik I, Fink M, Klebanoff L, Beckford A, Paik M, Wu Y. Effect of volume therapy on cerebral blood flow after subarachnoid hemorrhage. Neurology. 1994;44:A345. Abstract.","journal-title":"Neurology"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.STR.26.12.2260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T22:15:15Z","timestamp":1715552115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.STR.26.12.2260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1995,12]]}},"alternative-id":["10.1161\/01.STR.26.12.2260"],"URL":"https:\/\/doi.org\/10.1161\/01.str.26.12.2260","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,12]]},"assertion":[{"value":"1995-05-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1995-08-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1995-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}